GynecologyGynecologyГинекология2079-56962079-5831Consilium Medicum28459ArticlesСтатьиResearch ArticleThe possibility of reducing the risk of developing preeclampsia (review of foreign literature)Возможности снижения риска развития преэклампсии(обзор зарубежной литературы)LevakovS AЛеваковС АBorovkovaE IБоровковаЕ ИSheshukovaN AШешуковаН Аdr.sheshukova@mail.ruI.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian FederationГБОУ ВПО Первый Московский государственный медицинский университет им. И.М.Сеченова Минздрава России15062015173VOL 17, NO3 (2015)ТОМ 17, №3 (2015)525309042020Copyright ©; 2015, Consilium MedicumCopyright ©; 2015, ООО "Консилиум Медикум"2015Consilium MedicumООО "Консилиум Медикум"https://creativecommons.org/licenses/by-nc-sa/4.0https://gynecology.orscience.ru/2079-5831/article/view/28459

The article presents a review of international literature on the possibilities of prevention of pre-eclampsia in women at high risk. Given data from recent randomized trials and meta-analyses, have confirmed whether the use of low-dose antiplatelet therapy with 12 weeks of pregnancy to prevent the development of pre-eclampsia.

В статье представлен обзор зарубежной литературы, посвященный возможностям профилактики развития преэклампсии у женщин из группы высокого риска. Приведены данные последних рандомизированных исследований и метаанализов, подтвердивших целесообразность назначения низких доз антиагрегантов с 12 нед беременности для профилактики развития преэклампсии.

antiplatelet agentspreventionpre-eclampsiaантиагрегантыпрофилактикапреэклампсияLow - dose aspirin in prevention and treatment of intrauterine growth retardation and pregnancy - induced hypertension. Italian study of aspirin in pregnancy. Lancet 1993; 341: 396.Caritis S, Sibai B, Hauth J et al. Low - dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1998; 338: 701.CLASP: a randomised trial of low - dose aspirin for the prevention and treatment of pre - eclampsia among 9364 pregnant women. CLASP (Collaborative Low - dose Aspirin Study in Pregnancy) Collaborative Group. Lancet 1994; 343: 619.Duley L, Henderson-Smart D.J, Meher S, King J.F. Antiplatelet agents for preventing pre - eclampsia and its complications. Cochrane Database Syst Rev 2007; CD004659.Dekker G, Sibai B. Primary, secondary, and tertiary prevention of pre - eclampsia. Lancet 2001; 357: 209.Coomarasamy A, Honest H, Papaioannou S et al. Aspirin for prevention of preeclampsia in women with historical risk factors: a systematic review. Obstet Gynecol 2003; 101: 1319.Bates S.M, Greer I.A, Middeldorp S et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e691S.Bushnell C, Mc Cullough L.D, Awad I.A et al. Guidelines for the Prevention of Stroke in Women: A Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 2014.Barton J.R, Sibai B.M. Prediction and prevention of recurrent preeclampsia. Obstet Gynecol 2008; 112: 359.Askie L.M, Duley L, Henderson-Smart D.J et al. Antiplatelet agents for prevention of pre - eclampsia: a meta - analysis of individual patient data. Lancet 2007; 369: 1791.Roberge S, Nicolaides K.H, Demers S et al. Prevention of perinatal death and adverse perinatal outcome using low - dose aspirin: a meta - analysis. Ultrasound Obstet Gynecol 2013; 41: 491.Meher S, Alfirevic Z. Aspirin for pre - eclampsia: beware of subgroup meta - analysis. Ultrasound Obstet Gynecol 2013; 41: 479.Sibai B.M, Caritis S.N, Thom E et al. Prevention of preeclampsia with low - dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. N Engl J Med 1993; 329: 1213.Subtil D, Goeusse P, Puech F et al. Aspirin (100 mg) used for prevention of pre - eclampsia in nulliparous women: the Essai Regional Aspirine Mere-Enfant study (Part 1). BJOG 2003; 110: 475.Sibai B, Dekker G, Kupferminc M. Pre - eclampsia. Lancet 2005; 365: 785.Villa P.M, Kajantie E, Raikkonen K et al. Aspirin in the prevention of pre - eclampsia in high - risk women: a randomised placebo - controlled PREDO Trial and a meta - analysis of randomised trials. BJOG 2013; 120: 64.American College of Obstetricians and Gynecologists' Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Obstet Gynecol 2013; 122: 1122.Knight M, Duley L, Henderson-Smart D.J, King J.F. Antiplatelet agents for preventing and treating pre - eclampsia. Cochrane Database Syst Rev 2000; CD000492.Visintin C, Mugglestone M.A, Almerie M.Q et al. Management of hypertensive disorders during pregnancy: summary of NICE guidance. BMJ 2010; 341: c2207.Bujold E, Roberge S, Lacasse Y et al. Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta - analysis. Obstet Gynecol 2010; 116: 402.Hirsh J, Guyatt G, Albers G.W et al. Executive summary: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 2008; 133: 71S.Schiff E, Barkai G, Ben-Baruch G, Mashiach S. Low - dose aspirin does not influence the clinical course of women with mild pregnancy - induced hypertension. Obstet Gynecol 1990; 76: 742.